BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer
January 02, 2018 08:01 ET
|
BIOLIFE4D Corporation
CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr....
BIOLIFE4D Helping Others to Give the Gift of Time this Holiday Season
December 20, 2017 09:00 ET
|
BIOLIFE4D Corporation
CHICAGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is taking...
BIOLIFE4D Comments on New Guidelines for High Blood Pressure in Adults
December 05, 2017 08:01 ET
|
BIOLIFE4D Corporation
CHICAGO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on a new report from...
SENS Research Foundation Announces New Research Program on Dysfunctional White Blood Cells With Buck Institute for Research on Aging
April 24, 2017 08:00 ET
|
SENS Research Foundation
MOUNTAIN VIEW, CA--(Marketwired - April 24, 2017) - SENS Research Foundation (SRF) has launched a new research program focused on dysfunctional white blood cells in collaboration with the Buck...
SPEC Sensors Announces UL Recognition for Its High Sensitivity Carbon Monoxide Sensor
June 15, 2016 11:30 ET
|
SPEC Sensors
NEWARK, CA--(Marketwired - June 15, 2016) - SPEC Sensors 3SP_CO_1000 has been independently tested by UL and determined that it conforms to UL STD 2034, and UL STD 2075. The UL Recognized component...
HeartMate 3 CE Mark Trial 1-Year Results Presented at ISHLT 36th Annual Meeting and Scientific Sessions in Washington, D.C.
April 28, 2016 11:13 ET
|
International Society for Heart and Lung Transplantation
WASHINGTON, April 28, 2016 (GLOBE NEWSWIRE) -- At today's opening plenary session at the 36th Annual International Society for Heart and Lung Transplantation (ISHLT) Meeting & Scientific Sessions,...
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
March 17, 2016 07:00 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...